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Abstract 
A contribution to a special issue on Hormones and Human Competition. 
Financial markets are periodically destabilized by bubbles and crashes during which investors 
display respectively what has been called 'irrational exuberance' and 'irrational pessimism'. How 
can we best study these pathologies in competitive and risk-taking behaviors? In this article, we 
argue that a science of risk-taking and of the financial markets needs to draw heavily on 
physiology and especially endocrinology, due to their central roles in moderating human 
behaviour. Importantly, this science of competition and risk requires the same spectrum of 
research protocols as is found in mature biological and medical sciences, a spectrum running 
from field work conducted within financial institutions themselves to more controlled laboratory 
studies, which permit cause to be distinguished from effect. Such a spectrum of studies is 
especially important for translational behavioural science. 
 
Highlights 
- Cycles in financial markets tend to overshoot levels that could be justified by current earnings 
- Risk preferences appear to shift pro-cyclically 
- Endocrine systems play a role in shifting risk preferences 
- Understanding shifting risk preferences and market instability requires a combination of field 
and laboratory work. 
 
Key words 
Testosterone. Cortisol.  Financial market. Bubble. Financial crisis. Risk preference. Exuberance. 
Pessimism.
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Introduction  
The financial markets present us with the largest and most intense competitive forum ever 
constructed. Here the outcome of competition is, according to classical economic theory, an 
optimal allocation of capital to the projects with the highest returns and, thus, an increase in 
global prosperity. Financial markets can admittedly be volatile and do cycle between ‘bull’ and 
‘bear’ markets. These cycles have an average period of five to six years and can be considered 
healthy responses to the ebb and flow of credit, and to technological and economic opportunity. 
Unfortunately, the cycles tend to overshoot (Shiller & Page, 1981), occasionally to such an 
extreme that they threaten the stability of the global economy.  
 
For example, bull markets can morph into bubbles, in which investors display what has been 
termed ‘irrational exuberance’ - an unrealistic assessment of expected returns and of their own 
ability to predict the future; in contrast, bear markets can morph into financial crises, in which 
investors display ‘irrational pessimism’ - an almost complete aversion to risk. During bubbles and 
crashes investors typically react to price changes in a manner which is precisely the opposite to 
what economics would predict: the higher securities’ prices rise, the more investors buy them; the 
lower prices fall, the more investors shun them. Indeed, during the Credit Crisis of 2008-9 some 
argued that the markets had been pulled into a singularity in which the laws of economics no 
longer held true (Sornette and Cauwels, 2015). Irrational exuberance and pessimism in our 
competitive and risk-taking behaviours thus contribute significantly to instability in our financial 
system.  
 
So how can we gain a better appreciation of the factors that underlie these almost pathological 
forms of risk-taking? In this article, we propose an answer to this important question, reasoning 
that a science of risk-taking in the financial markets should not ignore the basic principles of 
physiology, and especially endocrinology, given their central roles in moderating human 
behaviour. Importantly, this science of risk should employ the same robust research tools and 
protocols as are commonly used in more mature biological and medical sciences – a spectrum 
which combines field work (in this case within financial institutions) with more controlled 
laboratory studies (that allow distinction between ‘cause’ and ‘effect’). 
 
Behaviour during extreme market volatility 
Research on market phenomena occurring during non-volatile times can be pursued successfully 
using commonly employed economic tools, such as axiomatic modelling, computerized decision 
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making tasks, questionnaires, etc., and with participants recruited from, for example, a student 
body or the wider population. But research on market phenomena that occur in what are 
commonly referred to as the ‘the tails’ (Fig. 1), in other words, when markets move three or more 
standard deviations – as is the case with bubbles and crashes – faces several challenges.  
 
To begin with, standard research tools may not be particularly well-suited to studying these 
extremes. For example, during tail events, such as the singularity of the 2007-09 Credit Crisis, the 
pressures felt by investors and traders were so intense that it is almost impossible for researchers 
to recreate these in a laboratory setting. Appreciating what a trader really experiences in the ‘heat 
of battle’ is challenging enough, but then recreating this in a group of volunteers who know that 
the task in hand is simulated (and they can therefore withdraw to safety at any stage without 
untoward consequence), means that the true range of physiological changes and emotions that the 
traders experience in real life are likely to be poorly reproduced in the artificial setting. 
 
 
Fig. 1. Normal distribution of stock market returns. X-axis units denote standard deviations from mean; Y-
axis denotes probability density.  
 
During bubbles, for example, investors and traders (many of whom are fresh out of college with 
no prior experience of making a lot of money) start enjoying above-average profits, their incomes 
spike to levels they have never before enjoyed, and they glimpse the possibility of real wealth. It 
is of course almost impossible to simulate this degree of euphoria with the payouts commonly 
Crashes Bubbles 
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made to participants in behavioural experiments (which are typically small amounts, and rarely 
exceed a few hundred dollars.)  
 
During financial crises and market crashes the same investors and traders suffer losses greater 
than anything they have ever contemplated; they face the loss of their jobs, even personal 
bankruptcy, and suffer the social shame of having to curtail the lavish lifestyle that accompanied 
their increased wealth during the prior bubble. These financial crises are particularly powerful 
events, with the daily news reports of failing financial institutions and hasty government and 
central bank interventions amplifying the fear spreading throughout the financial community. 
Unless one has experienced these tail events, or has observed first hand investors and traders 
caught up in them, it can be difficult to fully understand how profoundly they affect a person’s 
willingness and ability to take risks. Indeed, such challenges are inherent in any laboratory study 
of simulated competition (e.g. when studying the performance of elite athletes, it is difficult, if 
not impossible, to reproduce the uniqueness of real competition and the heat of the moment).  
 
A second difficulty in researching tail events stems from the existing tools that are commonly 
used to understand the markets. Most models in economics and finance are built upon the 
foundational assumption that risk preferences are a stable trait, much like a person’s height or eye 
colour (Sigler and Becker, 1977;  Luigino and Sugden 2007). So pervasive is this assumption that 
it is even found in the indices of risk appetite constructed by central banks (Gai and Vause, 2006; 
European Central Bank 2007). It did prove useful during the formulation of Neo-Classical 
economics and the core models of formal finance, such as the Capital Asset Pricing Model, 
because these models were built on the axioms of rational choice. Stable preferences were 
required because they ensured that choices were consistent.  
 
The models built upon this foundational assumption were elegant and highly influential. They 
even retained a core of commonsense in that they were informed by the not unreasonable belief 
that when people manage their money and try to maximize their wealth they act rationally. 
Unfortunately, however, this assumption does not seem compatible with the observed behaviour 
of investors during tail events. During bubbles investors appear to become more risk seeking and 
during crashes more risk averse. Indeed, since the credit crisis several studies have emerged 
(based on brokerage data) suggesting that risk aversion did increase during and after the crisis 
(Guiso 2013; Smith and Whitelaw, 2009; Cohen et al, 2015). 
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A third, and related, difficulty impairing our understanding of the markets is that most models in 
economics and finance assume risk-taking in this context to be a purely cognitive activity, i.e., 
that it can be understood by studying just the decisions themselves (employing tools such as 
logic, information theory, game theory, cognitive psychology, etc), but without reference to the 
physical changes taking place in the body of the risk taker. This assumption represents a profound 
misunderstanding of human biology and of the physiological pathways connecting body to brain. 
Body and brain evolved together and operate together. This unity of body and brain is evident 
when we take risk in, say, sports or war, because at these times the changes in our bodies – the 
quickened heart rate, increased breathing and blood pressure, the flood of both anabolic and stress 
hormones into the blood stream - is so overwhelming that we are readily aware of them (Coates, 
2012).  
 
It has been the hypothesis of the current authors that these somatic changes are also – and indeed 
especially –  important to risk-taking in the financial markets and for understanding the cycles of 
bubble and crash. We have found that risk preferences do in fact shift, that the shifts are large, 
and that the shifts are caused by alterations in physiology (Kandasamy, 2014). To study changing 
risk preferences, we have sought to apply insights and research protocols drawn from the 
disciplines of endocrinology and sports physiology to the world of finance. Importantly, our 
findings confirm that physiological changes, in particular fluctuations in classical endocrine 
pathways (anabolic and catabolic), are major determinants of changing risk preferences.  
 
Hormones and risk-taking 
Findings from sports physiology and from animal models such as John Wingfield’s Challenge 
Hypothesis (Wingfield et al, 1990) suggest that anabolic hormones can prepare the body and 
brain for competition. For example, testosterone promotes muscle hypertrophy and increases the 
level of haemoglobin in the blood and thus its capacity to carry oxygen (Bhasin et al., 2010). In 
the brain testosterone has been linked to increased confidence and search persistence in small 
mammals (Andrew and Rogers, 1972; Archer, 1977), and preference for novelty in both animal 
and human studies (Maattanen 2013; Boissy and Bouissou, 1994; Hermans et al, 2006); it 
interacts with dopaminergic circuits thereby making competitions euphorogenic (Schroeder and 
Packard, 2000; Frye et al, 2002); and it has been reported to increase appetite for risk, although 
some researchers contest such cause and effect  (Booth et al, 1999; Apicella et al, 2014; Apicella 
et al, 2015; Dreber, 2009).  
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Researchers in biology have postulated that the above mechanisms mediate the remarkable and 
related phenomenon known as the ‘winner effect’ in which an animal winning a competition 
enjoys an increased chance of winning its next competitive or agonistic encounter (Dugatkin, 
1013; Rutte et al, 2006; Lehner et al, 2011; Chase et al, 1994; Hsu and Wolf, 2001; Geniole et al, 
2017). Researchers have catalogued this phenomenon among a wide range of taxa, and a subset 
of these researchers, when looking for the underlying mechanism, have found that testosterone 
rises in the winner of a competition while falling in the loser. Furthermore, the winner’s 
androgenic priming gives it an edge in the next round of competition, leading to a feedback loop 
in which the very act of winning raises testosterone, which in turn contributes to further success 
(Oyegbile and Marler, 2005; Earley et al, 2013; Trainor et al, 2004; Oliveira et al, 2009; Fuxjager 
et al, 2010). Evidence of a testosterone-mediated winner effect has also been described in human 
male competitors (in both field and laboratory settings), although such an effect has not been 
universally observed (Booth et al, 1989; Carre and Putnam, 2010; Mazur et al, 1992; Carre  et al, 
2013; Zilioli and Watson, 2014). 
 
It is also likely that such a mechanism of empowerment could not continue indefinitely. In this 
context, it is interesting to speculate that testosterone, like several other hormones, may display 
an inverted U-shaped dose response curve, meaning that beyond an optimal (testosterone) level 
for a given competition, any further increase may actually impair performance. Evidence to 
support such a hypothesis is provided by animal studies in which elevated testosterone (i.e. raised 
beyond levels required for mating or normal territoriality) can encourage animals to fight too 
often, stray into the open, patrol areas too large, neglect parenting duties, and deplete fat/energy 
stores, all of which lead to increased vulnerability and even mortality (Wingfield et al, 2001; 
Dufty, 1989; Marler and Moore, 1988; Beletsky et al, 1995). At these elevated levels of 
testosterone, effective risk-taking morphs into risky behavior. Further studies, examining risk-
taking behaviours across a spectrum of (exogenously manipulated) testosterone concentrations in 
animal models would help to confirm the validity of the proposed U-shaped dose response curve. 
 
Several years ago, we developed the hypothesis that a variant of the winner effect is at work in 
the financial markets, during both individual winning streaks and more broadly during bubbles, 
which are market-wide winning streaks. At these times, traders and investors make above-average 
profits; their victories raise testosterone levels which, in turn, increase risk appetite and trade size 
(Coates and Herbert, 2008; Coates and Page, 2009; van Honk et al, 2004; Reavis and Overman, 
2001; Pope et al, 2000; Stanton et al, 2011). Eventually, however, traders go beyond the peak of 
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their inverted U-shaped response curve and any further increase in testosterone begins to impair 
risk-taking. Traders become over-confident and place bets in ever increasing size, with ever-
worsening risk-reward trade-offs, until eventually their trades go wrong and they suffer such large 
losses that they lose more money than they made on the winning streak.  
 
We also hypothesized that during bear markets – which so often spiral into financial crises and 
crashes - catabolic and stress mechanisms come to dominate risk-taking behaviour. During all 
competitive and risk-taking situations stress hormones such as adrenaline and cortisol promote an 
anticipatory arousal (Dickerson and Kemeny, 2004; Dallman and Bhatnagar, 2010). They prepare 
a person metabolically for impending physical activity, breaking down energy stores [liberating 
glucose in liver and muscle, free fatty acids in adipose tissue (fat depots)] to provide the fuel 
needed for this work, (i.e. driving catabolic processes throughout the body.) Acute increases in 
stress hormones raise blood glucose levels, increase heart rate and blood pressure, and inhibit 
bodily functions not required for immediate survival, such as digestion and reproduction. In the 
brain, cortisol (which crosses the blood-brain barrier) heightens recall of emotionally relevant 
memories (Lupien et al, 2002) and, by interacting with dopaminergic circuits, contributes to 
making acute risk-taking euphorogenic (Piazza and LeMoal, 1997; Sarnyai et al, 1998; Piazza et 
al, 1993; Putman et al, 2010).  
 
However, the effects of an acute (i.e. short-lived) rise in cortisol can differ dramatically from 
those of a chronic (i.e. sustained) elevation. When increased cortisol levels persist for days or 
weeks they can contribute to the development of gastric irritation (even frank ulceration), 
abdominal (visceral) obesity, insulin resistance and type 2 diabetes, abnormal blood lipid profiles, 
cardiovascular disease (Anagnostis et al, 2009) and impaired immune function (McEwen et al, 
1997). In the brain, chronically elevated cortisol impairs attentional control (Liston et al, 2009) 
and behavioural flexibility (Dias-Ferreira et al, 2009; Schwabe and Wolf, 2009); it promotes 
anxiety (Korte, 2001; Corodimas et al, 1994), a selective recall of disturbing memories (Erikson 
et al, 20003), a tendency to find danger where none exists (McEwen, 1998), even depression and 
learned helplessness (Sapolsky, 2000; Kademian et al, 2005). Given this suite of effects, it 
seemed reasonable to us to hypothesise that chronically elevated cortisol levels would also 
promote increased financial risk aversion.  
 
We thus developed an endocrine-based model to explain why financial market cycles tend to 
overshoot, become unstable, and require government and central bank intervention to restore 
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stability. During bull markets a financial variant of the winner effect causes risk preferences to 
shift towards greater risk seeking: the rising market leads to above-average profits; testosterone 
levels rise; confidence and trade size increase thereby contributing, on average, to increased 
profits. However, at some point in this upward spiral testosterone levels exceed the peak of the 
dose-response curve and begin to promote the irrational exuberance that pushes a bull market into 
a bubble. Once the bubble bursts and a bear market ensues, the increased uncertainty and 
volatility raises cortisol levels, and as this stress response persists and becomes chronic the 
cortisol promotes risk aversion and the irrational pessimism that pushes a bear market into a 
crash. In short, our endocrine system contributes to pro-cyclical shifts in risk appetite. 
 
Field work and laboratory studies – a complementary approach 
How do we test this model? For that matter, how do we test any model of shifting risk 
preferences in the financial markets? The classical scientific approach demands a controlled 
laboratory study; but ensuring that such a study is relevant and meaningful first requires 
observations in the field to help inform study design (SciBytes, 2013). On a trading floor, for 
example, this field work could involve monitoring risk takers’ physiology (their hormones, 
cardiovascular system, etc) as well as individual performance data (their profits and losses (P&L), 
market volatility, etc.). In fact, the model as presented here was not worked out a priori but was 
itself the result of extensive field work we conducted on trading floors in both New York and 
London before the 2008 financial crash, observing traders as they took real positions in the 
markets.  
 
Field work is an essential first step in scientific discovery. It permits researchers to observe 
phenomena that are unexpected or anomalous for existing theory, much like observing, for 
example, that the orbit of Mercury was other than that predicted by Newtonian mechanics, or that 
the geographical and fossil records could only be explained by a new theory of plate tectonics. In 
behavioural sciences, field work also presents researchers with an opportunity to identify 
problems in the private sector that would benefit from scientific study. In other words, field work 
provides external ecological validity for research. Field work is particularly important when 
researching financial market instability because, as highlighted above, it is difficult to replicate in 
a laboratory setting the pressures of real high-stakes risk-taking, or to predict by means of theory 
alone the behaviour resulting from this pressure.  
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Field work, however, has its drawbacks. To begin with, often it cannot establish causation once a 
correlation has been observed; and it can be difficult to control for potential third confounding 
variables. This does not mean that field work produces nothing more than ‘mere correlation’. 
Observation and correlation are the first steps in scientific discovery so should not be dismissed. 
Moreover, if one variable in a correlation is separated temporally from another, then this can 
provide a strong pointer to the primary aetiological factor (although third party confounding 
factors must still be considered). For example, when testing the winner effect hypothesis we 
noted in one study that when traders experienced high testosterone in the morning they made 
more money in the afternoon (Coates 2008). Here the high testosterone occurred before the 
trading profits, so we could argue with reasonable confidence that the testosterone predicted the 
profits.  
 
Importantly, the external validity provided by field work enables it to guide researchers as to 
where they should be focusing their attention in the laboratory setting. Laboratory work then 
permits the researchers to achieve internal validity, in other words, to control the variability in 
one parameter and to observe its effects, thereby confirming or excluding causation. In the 
laboratory additional variables can also be more readily controlled for; and the experimental 
protocol can be repeated more easily. 
 
Combining field and laboratory work in this way is common in biology and medicine. Instructive 
examples are found in the work of Robert Sapolsky and colleagues on the neurophysiology of the 
stress response (Sapolsky, 2004), and among many of the contributors to this special volume such 
as John Wingfield, Catherine Marler, and Coren Apicella. Their combination of field and 
laboratory work is, however, not so common in economics and finance (Eisenegger and Naef, 
2011). It is unfortunate that this should be so, for reasons already outlined. But there is a further 
reason in the case of financial risk-taking: the trade-off between the relevance of field work and 
the rigor of the laboratory is not as dramatic in financial phenomena. The authors’ experience has 
been that a trading floor presents a rare research venue where you can find the behaviours and 
pressures of the real world combined with elements of reproducibility/controllability that are 
more typical of a laboratory setting. 
 
There are various types of trading floors. The most well-known are the floors of stock exchanges, 
where brokers jostle and yell out orders. These have mostly been replaced today by computerized 
order matching systems, but a few remain, most notably in New York and Chicago. More 
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common are the trading floors of individual banks and trading firms. These may appear more 
sedate than the floors of exchanges, but the competition is nonetheless intense and the risks being 
taken are huge. On these floors, traders and asset managers sit at the same desk every day, 
surrounded by banks of computer screens on which are displayed real time news feeds and 
security prices. The traders have their allotted markets to trade and fixed risk limits; and in some 
sense they do the same thing every day – i.e. it is repeatable. And in that seat they experience in a 
compressed period of time levels of reward that are considerably higher than most people will 
experience in their entire lives and, equally intense, highly elevated levels of uncertainty and 
stress. The trading floor thus offers a rare venue in which to combine the rigor of the laboratory 
with the relevance of the field. 
 
Volatility and the stress response 
An example of research into financial risk-taking conducted along the methodological lines 
outlined here may be instructive. In one of our studies on a trading floor we set about testing for a 
testosterone-mediated winner effect in traders. We also screened for something akin to a cortisol-
mediated loser effect in which, we hypothesized, that trading losses might be amplified by rising 
levels of the stress hormone cortisol. But this latter hypothesis was not confirmed by the data: 
losing money did not seem to have a large effect on the traders’ cortisol levels (Coates and 
Herbert, 2008). This was surprising. It is possible that the risk management at this firm was good 
enough to stop traders from losing much money, and that larger losses than we observed would 
have triggered a rise in cortisol. But what we observed instead was that the traders’ cortisol levels 
were remarkably sensitive to the variance in their profits and losses (P&L), and to volatility in the 
market. This opened up a line of enquiry that we had not previously considered. 
 
On reflection, this finding is consistent with what is already known about situations that are 
associated with changes in cortisol status. For example, cortisol levels increase as a result of 
insult/injury, but a similar rise can be seen in situations where no harm has actually occurred, but 
only anticipated (Hennessy and Levine, 1979). Here the cortisol surge is part of a preparatory 
stress response, much like an early warning system that places our physiology on high alert. 
These situations are ones of novelty, uncontrollability, and uncertainty (Hennessy and Levine, 
1979). Each of these is a permanent feature of the financial markets, so in retrospect it should not 
have come as a surprise that traders’ cortisol levels were as volatile as we found.  
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We were able to proxy uncontrollability in the experiences of traders by using the variance of 
their P&L. A trader in control will have a relatively constant P&L, but as he or she loses control, 
making money one day, losing it the next, the variance of their P&L rises. We found that cortisol 
levels of the traders rose with the variance of their P&L (R
2
=0.47, p=0.002) (Coates & Herbert, 
2008). We were also able to proxy the uncertainty faced by the traders by using the volatility of 
the markets: the higher the volatility, the wider the dispersion of future prices traders must use in 
predicting returns. For example, the VIX is an index of volatilities on U.S. stocks and it has been 
called the Fear Index as it is a sensitive indicator of uncertainty among the financial community. 
During the Credit Crisis of 2008-9 the VIX spiked from 12% to over 70%. In our study we found 
that over a two week period mean daily cortisol levels on the trading floor rose and fell in line 
with volatility in the German Bond market (which was the market in which all traders were 
placing their bets); and that the hormones and volatility were highly correlated (R
2
=0.86, 
p=0.001). This remarkably high correlation has since been replicated in as-yet unpublished 
studies set in different markets and firms (Coates & Gurnell, unpublished data). 
 
Another notable finding in this study was that cortisol levels in the traders rose 68% over an 
eight-day period (Coates 2008) – i.e. the traders experienced sustained (chronic) elevation of 
cortisol (which contrasts with the transient rise that might be seen in an acute (short-lived) stress 
response (Schultz et al, 1998). The question thus arose: is this observation important? Did the 
increase in cortisol itself affect the traders’ risk-taking behaviour? 
 
To answer these questions, we took our findings in the field back to the laboratory. Using a 
double-blind, placebo controlled, cross-over study design (i.e. a format commonly used to assess 
the efficacy and safety of a new medicine/technology before it can be considered for use in 
routine clinical practice), we examined the effects of both acute and more sustained elevations in 
cortisol (Kandasamy et al, 2014). One group of participants received synthetic cortisol, in the 
form of hydrocortisone tablets, for eight days, followed by a washout period, then eight days of 
placebo tablets. A second group of participants followed the reverse schedule, i.e. placebo-
washout-treatment. A third sub-group received placebo-washout-placebo to test for learning 
effects on the behavioural tasks (i.e. changes occurring independent of cortisol status). The dosing 
regimen was designed to replicate the natural increase in cortisol levels that we had previously 
observed in the traders. Previous studies that have examined the effects of changes in endocrine 
status on psychological and physical parameters have more often than not fallen into the trap of 
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using supraphysiological dosages that immediately call in to question the relevance of their 
findings to normal physiology.  
 
The study protocol we designed therefore had several key features: 
 
1) Treatment was tailored to individual participants, i.e. we avoided a ‘one size fits all’ 
approach (whereby everyone receives the same dose), and instead based dosing schedules 
on body weight (thereby adopting a well-validated algorithm which has been used in 
clinical practice to calculate daily cortisol requirements in patients with adrenal failure 
(Mah et al, 2004), and adjusted to raise subjects cortisol levels by 68% over the eight 
days of the study  
2) Dosing schedules induced a sustained rise in cortisol throughout the study period, 
abolishing the normal diurnal (circadian) rhythm of cortisol production, and reproducing 
the profile observed in stressed individuals; to achieve this, we used a multi-dosing 
regimen (thrice daily – in the morning, early afternoon and evening)  
3) Participants collected salivary samples at home at several time points during the 8-day 
study period – thereby allowing us to assay for cortisol and confirm compliance with the 
dosing protocol 
4) The behavioural tasks were incentivized so that the participants tried at all times to make 
as much money as possible on the trading tasks. To achieve this, subjects were offered 
the possibility of making over $425 on the study. 
 
At the beginning and end of each phase (active and placebo, placebo and active, or placebo and 
placebo), participants played a computerized gambling task in which they had to choose between 
lotteries offering different combinations of monetary returns and probabilities. We succeeded in 
raising participants’ cortisol levels by an average of 69% over the eight days of the study, thereby 
replicating almost exactly the levels observed in traders. Crucially, this had the effect of shifting 
participants’ risk preferences so that they preferred safer lotteries, ones with lower expected 
returns but with lower variance of returns. In other words, they became significantly more risk 
averse, with an effect size that was large (risk aversion increased by 44%). In contrast, a short-
lived elevation in cortisol (assessed by repeating the computerized task on the first day of the 
study 90 minutes after taking the first hydrocortisone tablet) had no discernible effect on risk 
preferences (Fig. 2.) (Kandasamy et al, 2014). 
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A. 
 
B. 
Fig. 2. A. sample lottery used in computer task.. B. Changes in the expected return and variance of the 
chosen lotteries. Under chronically raised cortisol participants chose safer lotteries (i.e., ones with lower 
payoffs and a lower variance of possible payoffs). Results are shown as means ± SEMs. (Reproduced from 
Kanadasamy et al, PNAS, 2014. 
  
In this series of studies, we began with the unexpected finding that trader cortisol levels tracked 
volatility closely over a period of several days. Subsequent laboratory work showed that these 
hormone changes can affect a core parameter of risk-taking, the traders’ risk preferences. 
Contrary to the assumptions of much formal economics and finance, it appears therefore that risk 
preferences do shift; the shifts are large; and it is our physiology, in this case our HPA axis, that 
is bringing about these shifts.  
 
Specifically, the findings from our field work provide clear evidence that extended periods of 
high uncertainty and volatility raise cortisol levels; and the findings from our lab studies show 
that, in time, this increased cortisol raises risk aversion itself. When does volatility in the financial 
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markets rise the most? During bear markets. So just when the markets are becoming cheap and 
should be bought, and when the markets are most in need of support, the financial community 
becomes more risk averse. This risk aversion accelerates the downward movement of the 
markets. Cortisol mediated risk-aversion may therefore be destabilizing our financial markets.   
 
Conclusion  
 
In this article, we have argued the case that behavioural and policy sciences such as finance and 
economics should combine field and laboratory work in a manner similar to that employed in 
other scientific disciplines (e.g. biology, medicine). If research questions are based on 
observations made in the real world (i.e. in financial institutions and in the markets), and then 
subjected to rigorous scientific analysis in the laboratory, we can be confident that some of the 
hitherto unexplained fluctuations in the markets, with wide-reaching ramifications for the global 
economy, will begin to be better understood.     
 
In the case described here, we believe the demonstration of hormone-induced changes in risk 
preferences could help financial institutions, central banks and regulators recognize that an under-
appreciated and destabilizing factor in the financial markets is the instability and pro-cyclical 
nature of risk preferences. 
 
Knowing that risk preferences shift under the influence of physiological systems could then help 
inform novel policy developments (Coates, 2012). For example, we know that stability in the 
markets requires a diversity of opinions – when some people sell a security you need others to 
buy it, otherwise market moves become exaggerated. Given the influence of physiology on risk 
preferences, it is tempting to speculate that stability may be served by greater physiological and 
endocrine diversity in the markets, a goal that might be achieved for example by employing a 
more even mix of men and women, young and old in financial institutions.   
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